268 related articles for article (PubMed ID: 23588582)
1. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.
De Cobelli F; Giganti F; Orsenigo E; Cellina M; Esposito A; Agostini G; Albarello L; Mazza E; Ambrosi A; Socci C; Staudacher C; Del Maschio A
Eur Radiol; 2013 Aug; 23(8):2165-74. PubMed ID: 23588582
[TBL] [Abstract][Full Text] [Related]
2. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
3. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
[TBL] [Abstract][Full Text] [Related]
6. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
Giganti F; Salerno A; Ambrosi A; Chiari D; Orsenigo E; Esposito A; Albarello L; Mazza E; Staudacher C; Del Maschio A; De Cobelli F
Radiol Med; 2016 Mar; 121(3):173-80. PubMed ID: 26392393
[TBL] [Abstract][Full Text] [Related]
8. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
[TBL] [Abstract][Full Text] [Related]
10. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Borggreve AS; Heethuis SE; Boekhoff MR; Goense L; van Rossum PSN; Brosens LAA; van Lier ALHMW; van Hillegersberg R; Lagendijk JJW; Mook S; Ruurda JP; Meijer GJ
Eur Radiol; 2020 Apr; 30(4):1896-1907. PubMed ID: 31822974
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
Zhao M; Zhao L; Yang H; Duan Y; Li G
Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yan LL; Zhang HK; Wang Y; Xu SN; Li HL; Qu JR
Abdom Radiol (NY); 2022 Oct; 47(10):3394-3405. PubMed ID: 35916943
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer.
Yuan Y; Pu H; Chen GW; Chen XL; Liu YS; Liu H; Wang K; Li H
Eur Radiol; 2021 Jan; 31(1):200-211. PubMed ID: 32740816
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
Blazic IM; Lilic GB; Gajic MM
Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
[TBL] [Abstract][Full Text] [Related]
16. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.
Ippolito D; Fior D; Trattenero C; Ponti ED; Drago S; Guerra L; Franzesi CT; Sironi S
World J Radiol; 2015 Dec; 7(12):509-20. PubMed ID: 26753066
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
18. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.
Lambregts DM; Beets GL; Maas M; Curvo-Semedo L; Kessels AG; Thywissen T; Beets-Tan RG
Eur Radiol; 2011 Dec; 21(12):2567-74. PubMed ID: 21822946
[TBL] [Abstract][Full Text] [Related]
19. ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients.
Chen Y; Xie T; Ye Z; Wang F; Long D; Jiang M; Fang J; Lin Q; Li K; Wang Z; Fu Z
Radiat Oncol; 2019 Nov; 14(1):192. PubMed ID: 31684999
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
